RANDY H THURMAN
CIK 1204059 · Executive Chairman · last filed 2026-05-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.21M
Companies
10
Total Filings
56
Lifetime Open-Market Net
-$393.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 5,593 | $1.22 | $6.8K | $2.1K | 6 | 2026-05-27 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 0 | $0.07 | $0 | -$772.6K | 6 | 2022-09-30 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 11,875 | $0.03 | $356 | $16.5K | 8 | 2021-03-26 |
| Outlook Therapeutics, Inc. (ONSIW) Delisted | Director | — | — | — | $0 | 3 | 2018-11-13 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | — | — | — | $0 | 1 | 2018-04-17 |
| Veradigm Inc. (MDRX) Delisted | Director | 105,014 | $6.81 | $715.1K | $150.8K | 7 | 2017-05-24 |
| LENS | Executive Chairman | 47,757 | $41.84 | $2.00M | $109.5K | 6 | 2017-03-22 |
| OFIX | Director | — | $9.31 | — | $0 | 1 | 2013-11-21 |
| BEAT | Chairman, President & CEO | 264,766 | $0.76 | $200.6K | $99.8K | 10 | 2011-05-03 |
| VIASYS HEALTHCARE INC (VAS) Delisted | Chairman, President & CEO | 51,334 | — | — | $0 | 3 | 2007-06-25 |
Recent Filings · Page 3 of 6
56 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-13 | Outlook Therapeutics, Inc. (ONSIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-25 | Outlook Therapeutics, Inc. (ONSIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-28 | Outlook Therapeutics, Inc. (ONSIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-17 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-24 | Veradigm Inc. (MDRX) Delisted | Grant (A) | +16,765 | $0 | EDGAR |
| 2017-03-22 | LENS | Grant (A) | +12,738 | $0 | EDGAR |
| 2017-03-10 | LENS | Exer (X) | +5,543 | $16.6K | EDGAR |
| 2016-08-09 | LENS | Grant (A) | +8,247 | $0 | EDGAR |
| 2016-05-26 | Veradigm Inc. (MDRX) Delisted | Grant (A) | +15,129 | $0 | EDGAR |
| 2015-11-30 | LENS | Buy (P) | +1,833 | $10.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.